Search

Displaying results 6041 - 6050 of 9333 in total
  1. Drug

    Pentamustine

    go.drugbank.com/drugs/DB21291
    Experimental

    The usage of the INN stem '-mustine' in the name indicates that Pentamustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.

  2. Drug

    Izilendustat

    go.drugbank.com/drugs/DB21532
    Experimental

    The usage of the INN stem '-dustat' in the name indicates that Izilendustat is a hypoxia inducible factor (HIF) prolyl hydroxylase inhibitor.

  3. Drug

    Civorebrutinib

    go.drugbank.com/drugs/DB21641
    Experimental

    The usage of the INN stem '-brutinib' in the name indicates that Civorebrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  4. Drug

    Razuprotafib

    go.drugbank.com/drugs/DB16353
    Investigational

    Razuprotafib, also known as AKB-9778, is a small-molecule inhibitor restoring Tie2 activation by inhibiting VE-PTP.

  5. Drug

    Emricasan

    go.drugbank.com/drugs/DB05408
    Investigational

    Emricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA.

  6. Drug

    Mesoheme

    go.drugbank.com/drugs/DB02577
    Experimental

    The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins.

  7. Drug

    Malonyl-CoA

    go.drugbank.com/drugs/DB04524
    Experimental

    A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.

  8. Drug

    KB109

    go.drugbank.com/drugs/DB16531
    Experimental

    KB109 is a prebiotic to feed healthy bacteria for them to to outcompete multi-drug resistance organisms.

  9. Drug

    Evifacotrep

    go.drugbank.com/drugs/DB21510
    Investigational

    The usage of the INN stem '-cotrep' in the name indicates that Evifacotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist.

  10. Drug

    Carafiban

    go.drugbank.com/drugs/DB19813
    Experimental

    The usage of the INN stem '-fiban' in the name indicates that Carafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).